Vatche Israbian

Accomplished Physician with extensive experience caring for patients in various capacities, offering compassionate bedside manner and dedication to quality patient care. Organized and dependable candidate successful at managing multiple priorities with a positive attitude. Willingness to take on added responsibilities to meet team goals. To seek and maintain full-time position that offers professional challenges utilizing interpersonal skills, excellent time management and problem-solving skills.

• 2014, Recertification – Diplomat in Critical Care Medicine
• 2013, Recertification – Diplomat in Pulmonary Diseases
• 2005, Recertification – Diplomat in Critical Care Medicine
• 2004, Recertification – Diplomat in Pulmonary Diseases
• 09/2001, Recertification – American Board of Internal Medicine
• 11/1995, Diplomat in Critical Care Medicine
• 11/1994, Diplomat in Pulmonary Diseases
• 09/1991, American Board of Internal Medicine
• 09/1989, Federation Licensing Examination (FLEX)
• 05/1989, Test of Spoken English (TSE)
• 01/1987, Foreign Medical Graduate Examination in the Medical Sciences
• 04/1981, Graduate Record Examination in Biology
• 06/1978, French Baccalaureate in Experimental Sciences
• 06/1978, Lebanese Baccalaurean in Experimental Sciences, Part II
• 07/1977, Lebanese Baccalaureate in Experimental Sciences, Part I

• Parkview Cancer Institute
• Parkview Regional Medical Center
• Parkview Hospital Randallia
• Parkview Physicians Group
• Parkview Mirro Center for Research & Innovation
• American Thoracic Society
• American College of Chest Physicians
• Fort Wayne Medical Society
• American Association for Bronchology and Interventional Pulmonary

1997 – Present, PPG Physician, Pulmonary, Critical Care & Sleep Medicine Dept., Parkview Health, Fort Wayne, Indiana

• Indiana, Indiana State Board of Medical Licensing, # 01040196A
• Indiana, Indiana State Board of Medical Licensing, CSR - Physician License (# 01040196B)
• Ohio, Ohio State Medical License, 1989 – Present (35-058726)
• Florida, Florida Health Medical License, 1/26/2024 – Present, Physician License (ME166467)

• 03/1999 – Present, Clinical Assistant Professor, Indiana University School of Medicine, Fort Wayne Center of Medical Education
• 1993-1997, Assistant Professor of Medicine, Texas A&M University, College of Medicine, Health Science Center, College Station, Texas

• 2015 – Present, Lung Tumor Site Team, Parkview Regional Medical Center
• 1999 – 2019, Member of Ethics Committee, Parkview Hospital Randallia, Fort Wayne, Indiana
• 1998 – 2004, Member of Pharmacy and Therapeutics Committee, Parkview Hospital Randallia, Fort Wayne, Indiana
• 01/1996 – 06/1997, Member of the Therapeutic Agents Subcommittee, Department of Pharmacy, Central Texas Veteran's Health Care System
• 10/1994 – 1996, Medical Executive Committee, Central Texas Veteran's Health Care System
• 12/1993 – 10/1997, Chairman, Critical Care Committee, Central Texas Veteran's Health Care System

• Standard Bronchoscopy with lavage, brush, biopsy endobronchial and transbronchial, needle aspirate and Gen-Cut needle, including Cryobiopsy for ILD and via Robotic bronchoscopy.
• Interventional Bronchoscopy, including Endobronchial Ultrasound (EBUS) with needle aspirate and core Lymph node forceps biopsy, Radial Ultrasound, Navigation Bronchoscopy with Super dimension, Robotic bronchoscopy including both Monarch and ION Bronchoscopy platforms. Special expertise in ION Robotic bronchoscopy. Cone beam CT C Spin-ios for biopsy guidance with Robotic bronchoscopy, Fiducial marker placement, dye marking of nodule/tumor for surgery, US guided biopsy of subcutaneous nodules/masses.
• Cryoablation of Peripheral lung tumor.
• Endobronchial debulking procedures: Cryotherapy with cryoprobe and Cryospray, Argon Plasma Coagulator (APC), High Radiofrequency snare polypectomy, electrocautery, Endobronchial stents, Photodynamic Therapy, use of endobronchial blockers and basket for foreign body removal.
• Thoracentesis including US guided, Chest tube placement, Pleur-X catheter placement, endobronchial valves for Bronchopleural fistula, intra pleural thrombolytics administration, chemical pleurodesis.
• Critical care procedures including, Endotracheal intubation, Percutaneous tracheostomy, Central line, arterial line, dialysis catheter placement, Zoll Catheter insertion for hypothermia management, thoracentesis, paracentesis, lumbar puncture, Ventilator management, ECMO management, Right heart catheterization (Swan Ganz catheter), bone marrow aspirate.
• Pulmonary function test and methacholine challenge test interpretation.

• 06/2001, Family Practice Residency Teacher of the year award, Fort Wayne, Indiana
• 1996, Family Practice Residency Teaching Award, Texas A&M University
• 06/1992, The Will Rodger's pulmonary fellowship award
• 05/1992, American Federation for Clinical Research Trainee Award
• 09/1984 – 06/1987, Calouste Gulbenkian Scholarship Award
• 1982 & 1983, Dianna Tamary Sabbagh Foundation Award
• 06/1981, Dean's Honor List

• 1997, Pfizer: 31,000 U.S. Dollars for investigation in Murine E5 monoclonal antibody against gram negative endotoxin in patients with severe sepsis.
• 10/1993, Texas A&M University: 145,000 U.S. Dollars for investigation on the mechanisms of asbestos-mediated cell injury

• 09/1995 – 05/1997, Randomized, double-blinded trial of murine E5 monoclonal antibody against gram negative endotoxin in severe sepsis.
• 1994 – 1995, Systemic corticosteroids in COPD exacerbation (SCOPE)
• 1994 – 1995, Double blind, placebo-controlled phase II study of aerosolized Recombinant human DNAse 1 in hospitalized patients with COPD Exacerbation.
• 07/1991 – 06/1993, Cyclic AMP as a Modulator of Asbestos-Mediated HPEC Injury. Investigation of the cellular and molecular mechanisms involved in its protective effects.
• 02/1982 – 06/1983, Master's Thesis Project: Effects of Pentobarbital Induced-Myocardial Failure and Treatment with Ouabain on Cardio dynamic Parameters and Myocardial Levels of Cyclic AMP and High-Energy Phosphate Compounds in Cat Heart-Lung Preparations.
• 07/1980 – 06/1981, Biomass and Algae Distribution along the coast of Beirut

• Manuscript, Dibutyryl cyclic AMP attenuates asbestos induced pulmonary epithelial cell cytotoxicity and decline in ATP levels, Am J Physiol, 267, Lung Cell Mol Physiol 11, L518-L525, 1994, Israbian VA, Weitzman SA, Kamp DW
• Manuscript, Asbestos causes DNA strand breaks in cultured pulmonary epithelial cells: Role of iron-catalyzed free radicals, Am J Physiol, 268, Lung Cell Mol Physiol 12, L471-L480, 1995, Kamp DW, Israbian VA, Preusen SE, Zhang CX, Weitzman SA
• Manuscript, Phytic acid, an iron chelator, attenuates pulmonary inflammation and fibrosis in rats after intratracheal instillation of asbestos, Toxicologic Pathology, 23, 689-695, 1995, Kamp DW, Israbian VA, Yeldandi AV, Panos RJ, Graceffa P, Weitzman SA
• Manuscript, Cyclic AMP analogues prevent asbestos induced injury by cell cycle inhibition, Asbestos Health Risks Volume 12 of the Sourcebook on Asbestos Diseases, 61-79, George A. Peters, Barbara J. Peters, Michie Publishers, Charlottesville, VA, 1996, Israbian VA, Weitzman SA, Kamp DW
• Manuscript, Endotracheal Sialolipoma: A case report, Chest, 2023, Sivaji S., Sinha A., Israbian VA
• Abstract, Dibutyril cyclic AMP attenuates asbestos induced human pulmonary epithelial cell injury, Clin Res, 40, 141A, 1992, Israbian VA, Weitzman SA, Kamp DW
• Abstract, Cigarette smoke extracts synergistically promote asbestos-induced injury to cultured pulmonary epithelial cells, Am Rev Respir Dis, 145, A333, 1992, Kamp DW, Greenberger MJ, Israbian VA, Sbalchiero JS, Preusen SE
• Abstract, Mechanism of dibutyril cyclic AMP attenuates asbestos-induced injury to human pulmonary epithelial-like cells, Am Rev Respir Dis, 147, A907, 1993, Israbian VA, Weitzman SA, Kamp DW
• Abstract, Phytic acid, an iron chelator, attenuates pulmonary inflammation and fibrosis in rats after intratracheal instillation of asbestos, Clin Res, 42(2), 148A, 1994, Kamp DW, Israbian VA, Yeldandi AV, Weitzman SA
• Abstract, Cyclic AMP attenuates asbestos-induced WI-26 cell injury by inducing a G2/M phase block, J Investigative Medicine, 1995, Israbian VA, Measel JW, Burgess TA, Weitzman SA, Kamp DW